Novadaq Technologies Inc. (NASDAQ:NVDQ) (TSE:NDQ) has received an average recommendation of “Hold” from the fifteen ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $12.00.

Several equities analysts have commented on the stock. Canaccord Genuity lowered shares of Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 price objective for the company. in a research report on Monday, July 10th. Zacks Investment Research upgraded shares of Novadaq Technologies from a “sell” rating to a “hold” rating in a research report on Friday, August 18th. Northland Securities reiterated a “hold” rating and set a $11.75 price objective on shares of Novadaq Technologies in a research report on Monday, August 14th. BidaskClub upgraded shares of Novadaq Technologies from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $11.75 target price on shares of Novadaq Technologies in a report on Friday, September 1st.

ILLEGAL ACTIVITY WARNING: “Novadaq Technologies Inc. (NVDQ) Receives Consensus Recommendation of “Hold” from Brokerages” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/11/05/novadaq-technologies-inc-nvdq-receives-consensus-recommendation-of-hold-from-brokerages.html.

Novadaq Technologies has a 1-year low of $5.84 and a 1-year high of $12.74. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.49 and a quick ratio of 3.30.

Several institutional investors have recently added to or reduced their stakes in the company. Vivaldi Capital Management LLC purchased a new position in Novadaq Technologies in the 2nd quarter worth about $133,397,000. Gamco Investors INC. ET AL purchased a new position in Novadaq Technologies in the 2nd quarter worth about $145,000. Virtu Financial LLC purchased a new position in Novadaq Technologies in the 2nd quarter worth about $157,000. Wolverine Trading LLC purchased a new position in Novadaq Technologies in the 2nd quarter worth about $254,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. purchased a new position in Novadaq Technologies in the 2nd quarter worth about $255,000. Hedge funds and other institutional investors own 75.38% of the company’s stock.

About Novadaq Technologies

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Analyst Recommendations for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.